A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions

DMM Disease Models and Mechanisms

Volumn 6, Issue 1, 2013, Pages 217-235

  Kraft, Robert ^a   Kahn, Allon ^a,g   Medina Franco, José L ^b   Orlowski, Mikayla L ^a   Baynes, Cayla ^a   Loṕez Vallejo, Fabian ^b   Barnard, Kobus ^a,c   Maggiora, Gerald M ^d,e   Restifo, Linda L ^a,e,f  

^a UNIVERSITY OF ARIZONA   (United States)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^c University of Arizona   (United States)

^d TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCYSTEINE; ADIPHENINE; ANISINDIONE; ANTIBIOTIC G 418; ANTIMETASTATIC AGENT; APIGENIN; ATORVASTATIN; BENZYL ISOTHIOCYANATE; BITHIONOL; CAFFEINE; CARBENOXOLONE; CEFTRIAXONE; CICLOPIROXOLAMINE; CLOXIQUINE; CYCLOCREATINE; CYPROTERONE; DEGUELIN; DIPROPHYLLINE; DYCLONINE; EMETINE; ESTRADIOL ACETATE; ESTRADIOL PROPIONATE; FASCIN; GEDUNIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; JUGLONE; LASALOCID; NEUROLEPTIC AGENT; UNINDEXED DRUG;

ARTICLE; BIOASSAY; BRAIN DEVELOPMENT; COGNITION; DROSOPHILA; DRUG STRUCTURE; FOOD AND DRUG ADMINISTRATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; METASTASIS INHIBITION; MOLECULAR LIBRARY; NERVE CELL CULTURE; NEURITE; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; BRAIN; BRAIN NEOPLASMS; CARRIER PROTEINS; CELLS, CULTURED; DROSOPHILA; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; DRUG SCREENING ASSAYS, ANTITUMOR; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MICROFILAMENT PROTEINS; MODELS, NEUROLOGICAL; NEOPLASM METASTASIS; NEURONAL PLASTICITY; NEURONS; NOOTROPIC AGENTS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 84872068693     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.008243     Document Type: Article

References (146)

1. Aiken, C. T., Tobin, A. J. and Schweitzer, E. S. (2004). A cell-based screen for drugs to treat Huntington's disease. Neurobiol. Dis. 16, 546-555.
2. Al-Alwan, M., Olabi, S., Ghebeh, H., Barhoush, E., Tulbah, A., Al-Tweigeri, T., Ajarim, D. and Adra, C. (2011). Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS ONE 6, e27339.
3. Anderson, S. (1984). Graphical representation of molecules and substructure-search queries in MACCS™. J. Mol. Graph. 2, 83-90.
4. Anilkumar, N., Parsons, M., Monk, R., Ng, T. and Adams, J. C. (2003). Interaction of fascin and protein kinase Cα: a novel intersection in cell adhesion and motility. EMBO J. 22, 5390-5402.
5. Aratyn, Y. S., Schaus, T. E., Taylor, E. W. and Borisy, G. G. (2007). Intrinsic dynamic behavior of fascin in filopodia. Mol. Biol. Cell 18, 3928-3940.
6. Ashburn, T. T. and Thor, K. B. (2004). Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673-683.
7. Bemis, G. W. and Murcko, M. A. (1996). The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 39, 2887-2893.
8. Bender, H. A. (1960). Studies on the expression of various singed alleles in Drosophila melanogaster. Genetics 45, 867-883.
9. Bhogal, B. and Jongens, T. A. (2010). Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention. Dis. Model. Mech. 3, 693-700.
10. Bolduc, F. V. and Tully, T. (2009). Fruit flies and intellectual disability. Fly (Austin) 3, 91-104.
11. Bryan, J., Edwards, R., Matsudaira, P., Otto, J. and Wulfkühle, J. (1993). Fascin, an echinoid actin-bundling protein, is a homolog of the Drosophila singed gene product. Proc. Natl. Acad. Sci. USA 90, 9115-9119.
12. Burke, S. N. and Barnes, C. A. (2006). Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 7, 30-40.
13. Cannon, T. D. (2010). Candidate gene studies in the GWAS era: the MET protooncogene, neurocognition, and schizophrenia. Am. J. Psychiatry 167, 369-372.
14. Cant, K., Knowles, B. A., Mooseker, M. S. and Cooley, L. (1994). Drosophila singed, a fascin homolog, is required for actin bundle formation during oogenesis and bristle extension. J. Cell Biol. 125, 369-380.
15. Cao, T. T., Chang, W., Masters, S. E. and Mooseker, M. S. (2004). Myosin-Va binds to and mechanochemically couples microtubules to actin filaments. Mol. Biol. Cell 15, 151-161.
16. Chapman, R. F. (1998). Nutrition. In The Insects-Structure and Function, pp. 69-93. Cambridge: Cambridge University Press.
17. Chen, J. and Herrup, K. (2008). Selective vulnerability of neurons in primary cultures and in neurodegenerative diseases. Rev. Neurosci. 19, 317-326.
18. Chen, L., Yang, S., Jakoncic, J., Zhang, J. J. and Huang, X. Y. (2010). Migrastatin analogues target fascin to block tumour metastasis. Nature 464, 1062-1066.
19. Coecke, S., Goldberg, A. M., Allen, S., Buzanska, L., Calamandrei, G., Crofton, K., Hareng, L., Hartung, T., Knaut, H., Honegger, P. et al. (2007). Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ. Health Perspect. 115, 924-931.
20. Cordle, A., Koenigsknecht-Talboo, J., Wilkinson, B., Limpert, A. and Landreth, G. (2005). Mechanisms of statin-mediated inhibition of small G-protein function. J. Biol. Chem. 280, 34202-34209.
21. Das, T. and Cagan, R. (2010). Drosophila as a novel therapeutic discovery tool for thyroid cancer. Thyroid 20, 689-695.
22. De Arcangelis, A., Georges-Labouesse, E. and Adams, J. C. (2004). Expression of fascin-1, the gene encoding the actin-bundling protein fascin-1, during mouse embryogenesis. Gene Expr. Patterns 4, 637-643.
23. de Ferranti, S. and Ludwig, D. S. (2008). Storm over statins - the controversy surrounding pharmacologic treatment of children. N. Engl. J. Med. 359, 1309-1312.
24. Deinhardt, K., Kim, T., Spellman, D. S., Mains, R. E., Eipper, B. A., Neubert, T. A., Chao, M. V. and Hempstead, B. L. (2011). Neuronal growth cone retraction relies on proneurotrophin receptor signaling through Rac. Sci. Signal. 4, ra82.
25. Denora, N., Trapani, A., Laquintana, V., Lopedota, A. and Trapani, G. (2009). Recent advances in medicinal chemistry and pharmaceutical technology - strategies for drug delivery to the brain. Curr. Top. Med. Chem. 9, 182-196.
26. Desai, U. A., Pallos, J., Ma, A. A., Stockwell, B. R., Thompson, L. M., Marsh, J. L. and Diamond, M. I. (2006). Biologically active molecules that reduce polyglutamine aggregation and toxicity. Hum. Mol. Genet. 15, 2114-2124.
27. Dueñas-González, A., García-López, P., Herrera, L. A., Medina-Franco, J. L., González-Fierro, A. and Candelaria, M. (2008). The prince and the pauper. A tale of anticancer targeted agents. Mol. Cancer 7, 82.
28. Ess, K. C. (2006). The neurobiology of tuberous sclerosis complex. Semin. Pediatr. Neurol. 13, 37-42.
29. Evans, M. A. and Golomb, B. A. (2009). Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy 29, 800-811.
30. Fu, H., Wen, J. F., Hu, Z. L., Luo, G. Q. and Ren, H. Z. (2009). Knockdown of fascin1 expression suppresses the proliferation and metastasis of gastric cancer cells. Pathology 41, 655-660.
31. Galatti, L., Polimeni, G., Salvo, F., Romani, M., Sessa, A. and Spina, E. (2006). Short-term memory loss associated with rosuvastatin. Pharmacotherapy 26, 1190-1192.
32. Gan, B., Sahin, E., Jiang, S., Sanchez-Aguilera, A., Scott, K. L., Chin, L., Williams, D. A., Kwiatkowski, D. J. and DePinho, R. A. (2008). mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc. Natl. Acad. Sci. USA 105, 19384-19389.
33. Giese, A., Bjerkvig, R., Berens, M. E. and Westphal, M. (2003). Cost of migration: invasion of malignant gliomas and implications for treatment. J. Clin. Oncol. 21, 1624-1636.
34. Golomb, B. A., Kane, T. and Dimsdale, J. E. (2004). Severe irritability associated with statin cholesterol-lowering drugs. QJM 97, 229-235.
35. Golomb, B. A., McGraw, J. J., Evans, M. A. and Dimsdale, J. E. (2007). Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf. 30, 669-675.
36. Greenspan, R. J. and Dierick, H. A. (2004). 'Am not I a fly like thee?' From genes in fruit flies to behavior in humans. Hum. Mol. Genet. 13 Suppl. 2, R267-R273.
37. Guild, G. M., Connelly, P. S., Ruggiero, L., Vranich, K. A. and Tilney, L. G. (2003). Long continuous actin bundles in Drosophila bristles are constructed by overlapping short filaments. J. Cell Biol. 162, 1069-1077.
38. Gunal, A., Onguru, O., Safali, M. and Beyzadeoglu, M. (2008). Fascin expression in glial tumors and its prognostic significance in glioblastomas. Neuropathology 28, 382-386.
39. Hall, A. and Lalli, G. (2010). Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harb. Perspect. Biol. 2, 1-18.
40. Harrap, K. R. (1985). Preclinical studies identifying carboplatin as a viable cisplatin alternative. Cancer Treat Rev. 12 Suppl. A, 21-33.
41. Hashimoto, Y., Parsons, M. and Adams, J. C. (2007). Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis. Mol. Biol. Cell 18, 4591-4602.
42. Hashimoto, Y., Kim, D. J. and Adams, J. C. (2011). The roles of fascins in health and disease. J. Pathol. 224, 289-300.
43. Heemskerk, J. (2005). Screening existing drugs for neurodegeneration: The National Institute of Neurologic Disorders and Stroke (NINDS) model. Retina 25, S56-S57.
44. Herlenius, E. and Lagercrantz, H. (2001). Neurotransmitters and neuromodulators during early human development. Early Hum. Dev. 65, 21-37.
45. Hwang, J. H., Smith, C. A., Salhia, B. and Rutka, J. T. (2008). The role of fascin in the migration and invasiveness of malignant glioma cells. Neoplasia 10, 149-159.
46. Inlow, J. K. and Restifo, L. L. (2004). Molecular and comparative genetics of mental retardation. Genetics 166, 835-881.
47. Ishikawa, R., Sakamoto, T., Ando, T., Higashi-Fujime, S. and Kohama, K. (2003). Polarized actin bundles formed by human fascin-1: their sliding and disassembly on myosin II and myosin V in vitro. J. Neurochem. 87, 676-685.
48. Ito, T. and Handa, H. (2012). Deciphering the mystery of thalidomide teratogenicity. Congenit. Anom. (Kyoto) 52, 1-7.
49. Jansen, S., Collins, A., Yang, C., Rebowski, G., Svitkina, T. and Dominguez, R. (2011). Mechanism of actin filament bundling by fascin. J. Biol. Chem. 286, 30087-30096.
50. Jawhari, A. U., Buda, A., Jenkins, M., Shehzad, K., Sarraf, C., Noda, M., Farthing, M. J., Pignatelli, M. and Adams, J. C. (2003). Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am. J. Pathol. 162, 69-80.
51. Jayo, A. and Parsons, M. (2010). Fascin: a key regulator of cytoskeletal dynamics. Int. J. Biochem. Cell Biol. 42, 1614-1617.
52. Johnson, M. A. and Maggiora, G. A. (eds) (1990). Concepts and Applications of Molecular Similarity, pp. 393. New York, NY: Wiley-Interscience.
53. Johnston, M. V. (2004). Clinical disorders of brain plasticity. Brain Dev. 26, 73-80.
54. Jolliffe, I. T. (2002). Principal Component Analysis. New York, NY: Springer Series in Statistics.
55. Judson, M. C., Eagleson, K. L. and Levitt, P. (2011). A new synaptic player leading to autism risk: Met receptor tyrosine kinase. J. Neurodev. Disord. 3, 282-292.
56. Kalkunte, R., Macarthur, D. and Morton, R. (2007). Glioblastoma in a boy with fragile X: an unusual case of neuroprotection. Arch. Dis. Child. 92, 795-796.
57. Karlsgodt, K. H., Sun, D., Jimenez, A. M., Lutkenhoff, E. S., Willhite, R., van Erp, T. G. and Cannon, T. D. (2008). Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev. Psychopathol. 20, 1297-1327.
58. Kim, M. Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H., Norton, L. and Massagué, J. (2009a). Tumor self-seeding by circulating cancer cells. Cell 139, 1315-1326.
59. Kim, W. Y., Gonsiorek, E. A., Barnhart, C., Davare, M. A., Engebose, A. J., Lauridsen, H., Bruun, D., Lesiak, A., Wayman, G., Bucelli, R. et al. (2009b). Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation. J. Neurochem. 108, 1057-1071.
60. Kim, S. J., Choi, I. J., Cheong, T. C., Lee, S. J., Lotan, R., Park, S. H. and Chun, K. H. (2010). Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 138, 1035-1045, e1-e2.
61. King, D. S., Wilburn, A. J., Wofford, M. R., Harrell, T. K., Lindley, B. J. and Jones, D. W. (2003). Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 23, 1663-1667.
62. Kraft, R., Levine, R. B. and Restifo, L. L. (1998). The steroid hormone 20-hydroxyecdysone enhances neurite growth of Drosophila mushroom body neurons isolated during metamorphosis. J. Neurosci. 18, 8886-8899.
63. Kraft, R., Escobar, M. M., Narro, M. L., Kurtis, J. L., Efrat, A., Barnard, K. and Restifo, L. L. (2006). Phenotypes of Drosophila brain neurons in primary culture reveal a role for fascin in neurite shape and trajectory. J. Neurosci. 26, 8734-8747.
64. Kreis, P. and Barnier, J. V. (2009). PAK signalling in neuronal physiology. Cell. Signal. 21, 384-393.
65. Kureishy, N., Sapountzi, V., Prag, S., Anilkumar, N. and Adams, J. C. (2002). Fascins, and their roles in cell structure and function. Bioessays 24, 350-361.
66. Landrigan, P. J. (2010). What causes autism? Exploring the environmental contribution. Curr. Opin. Pediatr. 22, 219-225.
67. Langdon, S. R., Ertl, P. and Brown, N. (2010). Bioisosteric replacement and scaffold hopping in lead generation and optimization. Mol. Inf. 29, 366-385.
68. Li, A., Dawson, J. C., Forero-Vargas, M., Spence, H. J., Yu, X., König, I., Anderson, K. and Machesky, L. M. (2010a). The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr. Biol. 20, 339-345.
69. Li, L., Mauric, V., Zheng, J. F., Kang, S. U., Patil, S., Höger, H. and Lubec, G. (2010b). Olfactory bulb proteins linked to olfactory memory in C57BL/6J mice. Amino Acids 39, 871-886.
70. Lin, D. M. and Goodman, C. S. (1994). Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 13, 507-523.
71. Lipkus, A. H., Yuan, Q., Lucas, K. A., Funk, S. A., Bartelt, W. F., 3rd, Schenck, R. J. and Trippe, A. J. (2008). Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry. J. Org. Chem. 73, 4443-4451.
72. Liu, A. C., Welsh, D. K., Ko, C. H., Tran, H. G., Zhang, E. E., Priest, A. A., Buhr, E. D., Singer, O., Meeker, K., Verma, I. M. et al. (2007). Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell 129, 605-616.
73. Machesky, L. M. and Li, A. (2010). Fascin: Invasive filopodia promoting metastasis. Commun. Integr. Biol. 3, 263-270.
74. Maggiora, G. M. and Shanmugasundaram, V. (2011). Molecular similarity measures. In Chemoinformatics and Computational Chemical Biology (ed. J. Bajorath), pp. 39-100. New York: Humana Press, Springer.
75. Mangiola, A., Anile, C., Pompucci, A., Capone, G., Rigante, L. and De Bonis, P. (2010). Glioblastoma therapy: going beyond Hercules Columns. Expert Rev. Neurother. 10, 507-514.
76. Marín-Vicente, C., Guerrero-Valero, M., Nielsen, M. L., Savitski, M. M., Gómez-Fernández, J. C., Zubarev, R. A. and Corbalán-García, S. (2011). ATP enhances neuronal differentiation of PC12 cells by activating PKCα interactions with cytoskeletal proteins. J. Proteome Res. 10, 529-540.
77. Medina-Franco, J. L., Petit, J. and Maggiora, G. M. (2006). Hierarchical strategy for identifying active chemotype classes in compound databases. Chem. Biol. Drug Des. 67, 395-408.
78. Medina-Franco, J. L., Martínez-Mayorga, K., Bender, A. and Scior, T. (2009). Scaffold diversity analysis of compound data sets using an entropy-based measure. QSAR Comb. Sci. 28, 1551-1560.
79. Megiorni, F., Indovina, P., Mora, B. and Mazzilli, M. C. (2005). Minor expression of fascin-1 gene (FSCN1) in NTera2 cells depleted of CREB-binding protein. Neurosci. Lett. 381, 169-174.
80. Meller, R. (2009). The role of the ubiquitin proteasome system in ischemia and ischemic tolerance. Neuroscientist 15, 243-260.
81. Miles, W. O., Dyson, N. J. and Walker, J. A. (2011). Modeling tumor invasion and metastasis in Drosophila. Dis. Model. Mech. 4, 753-761.
82. Molli, P. R., Li, D. Q., Murray, B. W., Rayala, S. K. and Kumar, R. (2009). PAK signaling in oncogenesis. Oncogene 28, 2545-2555.
83. Muldoon, M. F., Ryan, C. M., Sereika, S. M., Flory, J. D. and Manuck, S. B. (2004). Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am. J. Med. 117, 823-829.
84. Munson, J. M., Fried, L., Rowson, S. A., Bonner, M. Y., Karumbaiah, L., Diaz, B., Courtneidge, S. A., Knaus, U. G., Brat, D. J., Arbiser, J. L. et al. (2012). Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. Sci. Transl. Med. 4, 127ra36.
85. Myers, J. L. and Well, A. D. (1991). Research Design and Statistical Analysis. New York: HarperCollins.
86. Nagy, S., Ricca, B. L., Norstrom, M. F., Courson, D. S., Brawley, C. M., Smithback, P. A. and Rock, R. S. (2008). A myosin motor that selects bundled actin for motility. Proc. Natl. Acad. Sci. USA 105, 9616-9620.
87. Narro, M. L., Yang, F., Kraft, R., Wenk, C., Efrat, A. and Restifo, L. L. (2007). NeuronMetrics: software for semi-automated processing of cultured neuron images. Brain Res. 1138, 57-75.
88. Niemi, M. (2010). Transporter pharmacogenetics and statin toxicity. Clin. Pharmacol. Ther. 87, 130-133.
89. Ono, S., Yamakita, Y., Yamashiro, S., Matsudaira, P. T., Gnarra, J. R., Obinata, T. and Matsumura, F. (1997). Identification of an actin binding region and a protein kinase C phosphorylation site on human fascin. J. Biol. Chem. 272, 2527-2533.
90. Opii, W. O., Joshi, G., Head, E., Milgram, N. W., Muggenburg, B. A., Klein, J. B., Pierce, W. M., Cotman, C. W. and Butterfield, D. A. (2008). Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiol. Aging 29, 51-70.
91. Palumbo, A., Facon, T., Sonneveld, P., Bladè, J., Offidani, M., Gay, F., Moreau, P., Waage, A., Spencer, A., Ludwig, H. et al. (2008). Thalidomide for treatment of multiple myeloma: 10 years later. Blood 111, 3968-3977.
92. Paterson, J. and O'Hare, K. (1991). Structure and transcription of the singed locus of Drosophila melanogaster. Genetics 129, 1073-1084.
93. Peraud, A., Mondal, S., Hawkins, C., Mastronardi, M., Bailey, K. and Rutka, J. T. (2003). Expression of fascin, an actin-bundling protein, in astrocytomas of varying grades. Brain Tumor Pathol. 20, 53-58.
94. Piccioni, F., Roman, B. R., Fischbeck, K. H. and Taylor, J. P. (2004). A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor. Hum. Mol. Genet. 13, 437-446.
95. Pilling, A. D., Horiuchi, D., Lively, C. M. and Saxton, W. M. (2006). Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in Drosophila motor axons. Mol. Biol. Cell 17, 2057-2068.
96. Roelfsema, J. H. and Peters, D. J. (2007). Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev. Mol. Med. 9, 1-16.
97. Roma, A. A. and Prayson, R. A. (2005). Fascin expression in 90 patients with glioblastoma multiforme. Ann. Diagn. Pathol. 9, 307-311.
98. Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S. et al. (2005). Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73-77.
99. Ryu, M. J., Kim, D., Kang, U. B., Kim, J., Shin, H. S., Lee, C. and Yu, M. H. (2007). Proteomic analysis of gamma-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure. J. Neurochem. 102, 646-656.
100. Ryu, M. J., Lee, C., Kim, J., Shin, H. S. and Yu, M. H. (2008). Proteomic analysis of stargazer mutant mouse neuronal proteins involved in absence seizure. J. Neurochem. 104, 1260-1270.
101. Safran, N., Haring, R., Gurwitz, D., Shainberg, A., Halili, I., Levy, A., Bogin, E. and Shahar, A. (1996). Selective neurotoxicity induced by the ionophore lasalocid in rat dissociated cerebral cultures, involvement of the NMDA receptor/channel. Neurotoxicology 17, 883-895.
102. Salhia, B., Tran, N. L., Symons, M., Winkles, J. A., Rutka, J. T. and Berens, M. E. (2006). Molecular pathways triggering glioma cell invasion. Expert Rev. Mol. Diagn. 6, 613-626.
103. Samuel, F. and Hynds, D. L. (2010). RHO GTPase signaling for axon extension: is prenylation important? Mol. Neurobiol. 42, 133-142.
104. Sawallisch, C., Berhörster, K., Disanza, A., Mantoani, S., Kintscher, M., Stoenica, L., Dityatev, A., Sieber, S., Kindler, S., Morellini, F. et al. (2009). The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. J. Biol. Chem. 284, 9225-9236.
105. Schulz, J. G., Bösel, J., Stoeckel, M., Megow, D., Dirnagl, U. and Endres, M. (2004). HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. J. Neurochem. 89, 24-32.
106. Sedeh, R. S., Fedorov, A. A., Fedorov, E. V., Ono, S., Matsumura, F., Almo, S. C. and Bathe, M. (2010). Structure, evolutionary conservation, and conformational dynamics of Homo sapiens fascin-1, an F-actin crosslinking protein. J. Mol. Biol. 400, 589-604.
107. Shalaeva, M., Kenseth, J., Lombardo, F. and Bastin, A. (2008). Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers. J. Pharm. Sci. 97, 2581-2606.
108. Shan, D., Chen, L., Njardarson, J. T., Gaul, C., Ma, X., Danishefsky, S. J. and Huang, X. Y. (2005). Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc. Natl. Acad. Sci. USA 102, 3772-3776.
109. Shin, J. H., Guedj, F., Delabar, J. M. and Lubec, G. (2007). Dysregulation of growth factor receptor-bound protein 2 and fascin in hippocampus of mice polytransgenic for chromosome 21 structures. Hippocampus 17, 1180-1192.
110. Shin, J. B., Longo-Guess, C. M., Gagnon, L. H., Saylor, K. W., Dumont, R. A., Spinelli, K. J., Pagana, J. M., Wilmarth, P. A., David, L. L., Gillespie, P. G. et al. (2010). The R109H variant of fascin-2, a developmentally regulated actin crosslinker in hair-cell stereocilia, underlies early-onset hearing loss of DBA/2J mice. J. Neurosci. 30, 9683-9694.
111. Singh, N., Guha, R., Giulianotti, M. A., Pinilla, C., Houghten, R. A. and Medina-Franco, J. L. (2009). Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. J. Chem. Inf. Model. 49, 1010-1024.
112. Slaugenhaupt, S. A., Mull, J., Leyne, M., Cuajungco, M. P., Gill, S. P., Hims, M. M., Quintero, F., Axelrod, F. B. and Gusella, J. F. (2004). Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum. Mol. Genet. 13, 429-436.
113. Sleeman, J. and Steeg, P. S. (2010). Cancer metastasis as a therapeutic target. Eur. J. Cancer 46, 1177-1180.
114. Sporn, M. B. (1996). The war on cancer. Lancet 347, 1377-1381.
115. Stavrovskaya, I. G., Narayanan, M. V., Zhang, W., Krasnikov, B. F., Heemskerk, J., Young, S. S., Blass, J. P., Brown, A. M., Beal, M. F., Friedlander, R. M. et al. (2004). Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology. J. Exp. Med. 200, 211-222.
116. Stella, G. M., Benvenuti, S. and Comoglio, P. M. (2010). Targeting the MET oncogene in cancer and metastases. Expert Opin. Investig. Drugs 19, 1381-1394.
117. Sun, B. and Salvaterra, P. M. (1995). Characterization of nervana, a Drosophila melanogaster neuron-specific glycoprotein antigen recognized by anti-horseradish peroxidase antibodies. J. Neurochem. 65, 434-443.
118. Svitkina, T. M., Bulanova, E. A., Chaga, O. Y., Vignjevic, D. M., Kojima, S., Vasiliev, J. M. and Borisy, G. G. (2003). Mechanism of filopodia initiation by reorganization of a dendritic network. J. Cell Biol. 160, 409-421.
119. Tamada, A., Kawase, S., Murakami, F. and Kamiguchi, H. (2010). Autonomous right-screw rotation of growth cone filopodia drives neurite turning. J. Cell Biol. 188, 429-441.
120. Tang, Z. L., Zhang, X. J., Yang, S. L., Mu, Y. L., Cui, W. T., Ao, H. and Li, K. (2010). The chromosomal localization, expression pattern and polymorphism analysis of porcine FSCN1 gene differently expressed from LongSAGE library. Mol. Biol. Rep. 37, 2361-2367.
121. Tatley, M. and Savage, R. (2007). Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid-lowering agents. Drug Saf. 30, 195-201.
122. Tilney, L. G., Tilney, M. S. and Guild, G. M. (1995). F actin bundles in Drosophila bristles. I. Two filament cross-links are involved in bundling. J. Cell Biol. 130, 629-638.
123. Tinetti, M. E. (2008). Over-the-counter sales of statins and other drugs for asymptomatic conditions. N. Engl. J. Med. 358, 2728-2732.
124. Traynor, B. J., Bruijn, L., Conwit, R., Beal, F., O'Neill, G., Fagan, S. C. and Cudkowicz, M. E. (2006). Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology 67, 20-27.
125. Tseng, Y., Kole, T. P., Lee, J. S., Fedorov, E., Almo, S. C., Schafer, B. W. and Wirtz, D. (2005). How actin crosslinking and bundling proteins cooperate to generate an enhanced cell mechanical response. Biochem. Biophys. Res. Commun. 334, 183-192.
126. Tubb, B. E., Bardien-Kruger, S., Kashork, C. D., Shaffer, L. G., Ramagli, L. S., Xu, J., Siciliano, M. J. and Bryan, J. (2000). Characterization of human retinal fascin gene (FSCN2) at 17q25: close physical linkage of fascin and cytoplasmic actin genes. Genomics 65, 146-156.
127. Tubb, B., Mulholland, D. J., Vogl, W., Lan, Z. J., Niederberger, C., Cooney, A. and Bryan, J. (2002). Testis fascin (FSCN3): a novel paralog of the actin-bundling protein fascin expressed specifically in the elongate spermatid head. Exp. Cell Res. 275, 92-109.
128. Verney, C. (2003). Phenotypic expression of monoamines and GABA in the early development of human telencephalon, transient or not transient. J. Chem. Neuroanat. 26, 283-292.
129. Vignjevic, D., Kojima, S., Aratyn, Y., Danciu, O., Svitkina, T. and Borisy, G. G. (2006). Role of fascin in filopodial protrusion. J. Cell Biol. 174, 863-875.
130. Vincent, A. M., Backus, C., Taubman, A. A. and Feldman, E. L. (2005). Identification of candidate drugs for the treatment of ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 6, 29-36.
131. Wagstaff, L. R., Mitton, M. W., Arvik, B. M. and Doraiswamy, P. M. (2003). Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 23, 871-880.
132. Wang, J., Gines, S., MacDonald, M. E. and Gusella, J. F. (2005a). Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation. BMC Neurosci. 6, 1.
133. Wang, W., Duan, W., Igarashi, S., Morita, H., Nakamura, M. and Ross, C. A. (2005b). Compounds blocking mutant huntingtin toxicity identified using a Huntington's disease neuronal cell model. Neurobiol. Dis. 20, 500-508.
134. Wang, C. Y., Liu, P. Y. and Liao, J. K. (2008). Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol. Med. 14, 37-44.
135. White, C. M. (2002). A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin. J. Clin. Pharmacol. 42, 963-970.
136. Willett, P., Barnard, J. M. and Downs, G. M. (1998). Chemical similarity searching. J. Chem. Inf. Comput. Sci. 38, 983-996.
137. Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B. and Hassanali, M. (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901-D906.
138. Wulfkühle, J. D., Petersen, N. S. and Otto, J. J. (1998). Changes in the F-actin cytoskeleton during neurosensory bristle development in Drosophila: the role of singed and forked proteins. Cell Motil. Cytoskeleton 40, 119-132.
139. Xu, Y. J. and Johnson, M. (2002). Using molecular equivalence numbers to visually explore structural features that distinguish chemical libraries. J. Chem. Inf. Comput. Sci. 42, 912-926.
140. Yamakita, Y., Matsumura, F. and Yamashiro, S. (2009). Fascin1 is dispensable for mouse development but is favorable for neonatal survival. Cell Motil. Cytoskeleton 66, 524-534.
141. Yamashiro, S., Yamakita, Y., Ono, S. and Matsumura, F. (1998). Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol. Biol. Cell 9, 993-1006.
142. Ye, X. and Carew, T. J. (2010). Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins. Neuron 68, 340-361.
143. Yoder, B. J., Tso, E., Skacel, M., Pettay, J., Tarr, S., Budd, T., Tubbs, R. R., Adams, J. C. and Hicks, D. G. (2005). The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin. Cancer Res. 11, 186-192.
144. Zanet, J., Stramer, B., Millard, T., Martin, P., Payre, F. and Plaza, S. (2009). Fascin is required for blood cell migration during Drosophila embryogenesis. Development 136, 2557-2565.
145. Zhang, F. R., Tao, L. H., Shen, Z. Y., Lv, Z., Xu, L. Y. and Li, E. M. (2008). Fascin expression in human embryonic, fetal, and normal adult tissue. J. Histochem. Cytochem. 56, 193-199.
146. Zins, G. R. (1988). The history of the development of minoxidil. Clin. Dermatol. 6, 132-147.